The 20 Best Undifferentiated Connective Tissue Disease (UCTD) Doctors Near Me in Maryland, US

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy. Dr. Petri is board certified in American Board Of Internal Medicine and American Board Of Allergy And Immunology.

Dr. Homa Timlin is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include systemic lupus erythematosus, and lupus nephritis. Dr. Timlin serves on the faculty of the Johns Hopkins Consultative Rheumatology Clinic. A member of the Royal College of Physicians, Dr. Timlin earned her medical degree at Romania’s Universitatea de Medicana Si Farmacie Carol Davila. Upon completion of rheumatology fellowships, Oxford in the United Kingdom and an internal medicine residency in the United States, she joined the Johns Hopkins Lupus Center in 2011. After a one-year postdoctoral lupus fellowship under the mentorship of Dr. Michelle Petri, she finished her post-doctoral fellowship in rheumatology at Johns Hopkins. She also holds a master’s degree in clinical immunology (London University), MRCP diploma (Member of the Royal College of Physicians), Certificate of Completion of Specialty Training (CCST). Dr. Timlin has been an active educator who works with trainees at all levels, nationally and internationally, in the inpatient and outpatient settings. Presently, Dr. Timlin has established a retrospective cohort of several hundred patients with lupus and lupus nephritis, and site lead at the Johns Hopkins Bayview Medical Center. Dr. Timlin is the medical chair for the local chapter of Lupus Foundation of America (LFA) and the director of an IRB-approved prospective human diagnostic study using magnetic resonance imaging (MRI) to evaluate lupus nephritis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Timlin is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE). Dr. Timlin is board certified in American Board Of Internal Medicine.

Ashu Mehta is a Rheumatologist practicing medicine in Crofton, Maryland. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Connective Tissue Disease (UCTD), Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica.

Nasser Nasseri is a Rheumatologist practicing medicine in Catonsville, Maryland. Dr. Nasseri is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD).

Peter Holt is a Rheumatologist practicing medicine in Abingdon, Maryland. Dr. Holt is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Connective Tissue Disease (UCTD), Rheumatoid Arthritis (RA), Gout, and Goodpasture Syndrome.

Jonathan Adelson is a Rheumatologist practicing medicine in Greenbelt, Maryland. Dr. Adelson is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses MASS Phenotype, Mixed Connective Tissue Disease, Antisynthetase Syndrome, and Eosinophilia-Myalgia Syndrome.

Howard Hauptman is a Rheumatologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 44 years. Dr. Hauptman is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica.

Tazeen Rehman is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Rehman is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Fibromyalgia. Dr. Rehman is board certified in American Board Of Internal Medicine - Rheumatology.

Rukmini Konatalapalli is an Internal Medicine provider practicing medicine in Greenbelt, Maryland. Dr. Konatalapalli is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Gout, Fibromyalgia, Rheumatoid Arthritis (RA), and Bursitis.

Maria Chou is a Rheumatologist practicing medicine in Clinton, Maryland. Dr. Chou is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Gout, Rheumatoid Arthritis (RA), Bursitis, and Tenosynovitis.

Yevgeniy Sheyn is a Rheumatologist practicing medicine in Clinton, Maryland. Dr. Sheyn is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Fibromyalgia, Gout, Vitamin D Deficiency, and Tenosynovitis.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis. Dr. Christopher is board certified in American Board Of Internal Medicine.

Andrea Fava is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Fava is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc). Dr. Fava is board certified in American Board Of Internal Medicine.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis. Dr. Wise is board certified in American Board Of Internal Medicine.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma. Dr. Wigley is board certified in American Board Of Internal Medicine.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema. Dr. Shah is board certified in American Board Of Internal Medicine.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma. Dr. Hummers is board certified in American Board Of Internal Medicine.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Scleroderma. Dr. Paik is board certified in American Board Of Internal Medicine.

Andrew Mammen is a Neuromusculoskeletal Medicine specialist and a Neurologist practicing medicine in Baltimore, Maryland. Dr. Mammen is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Necrotizing Myopathy (NM). Dr. Mammen is board certified in American Board Of Psychiatry And Neurology.

Dr. Brit Adler is an Assistant Professor of Medicine in the Division of Rheumatology at Johns Hopkins University. She is building a career as a translational physician-scientist with a focus on Postural Orthostatic Tachycardia Syndrome (POTS) and infection-associated chronic illnesses. Her interest in this area emerged from her work in general rheumatology, where she frequently encountered patients with POTS, an often-overlooked and understudied condition. She is particularly interested in investigating the immune dysregulation underlying POTS, Long COVID, and Chronic Lyme Disease. By leveraging her prior experience in autoantibody discovery in rheumatic diseases, Dr. Adler aims to deepen our understanding of these conditions. In addition to her work in general rheumatology, Dr. Adler leads a dedicated POTS clinic and evaluates patients in the Hopkins Autonomic Lab, furthering her commitment to improving care for patients with autonomic disorders. She earned her medical degree from Case Western Reserve University in Cleveland, Ohio, and completed her residency in Internal Medicine at the Hospital of the University of Pennsylvania. Following this, she pursued a clinical and research fellowship in Rheumatology at Johns Hopkins. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Adler is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Inclusion Body Myositis. Dr. Adler is board certified in American Board Of Internal Medicine.